Olive Oil and IBS: The Role of Fat in a Low-FODMAP Diet

Where Diet Management Meets IBS

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel habits. According to data from the World Gastroenterology Organisation (WGO), an estimated 10–15% of the global population experiences IBS symptoms. Dietary modification has become a cornerstone management strategy alongside pharmacological treatment, and the low-FODMAP diet — which restricts Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols — has been extensively studied in international gastroenterology research.

FODMAPs are specific carbohydrate types that are poorly absorbed in the small intestine and rapidly fermented in the large intestine. Wheat, garlic, onion, lactose, and fructose are among the foods most commonly cited as high-FODMAP. Dietary fat, by contrast, does not belong to the FODMAP classification system at all. So what role does fat actually play in an IBS-conscious diet?

Fat's Place in the Low-FODMAP Framework

According to guidelines from the Monash University research team that developed and validated the low-FODMAP protocol, pure plant-based oils contain no FODMAP components and are classified as unrestricted foods. Extra virgin olive oil (EVOO) sits firmly in that category.

Being FODMAP-free does not, however, automatically make a fat unconditionally beneficial for IBS management. Fat is a macronutrient capable of influencing gut motility and visceral sensory signaling. A literature review published by researchers at King's College London reported that high-fat meals may increase visceral hypersensitivity in some IBS patients. This places the type of fat and the way it is consumed at the center of the conversation.

Olive Oil's Fatty Acid Profile and Gut Sensitivity Research

The dominant component of extra virgin olive oil is oleic acid, a monounsaturated fatty acid that accounts for 55–83% of total fat content. Oleic acid is generally considered to produce a comparatively moderate stimulus on gut motility relative to saturated fatty acids.

EVOO also contains phenolic compounds including oleocanthal and hydroxytyrosol. Cell and animal studies by researchers at the Universidad de Córdoba have reported that these phenolic compounds may interact with intestinal inflammatory pathways. Researchers are careful to note, however, that extrapolating these findings directly to IBS patients is premature and that clinical evidence remains insufficient to draw firm conclusions.

A systematic review published in Nutrients in 2022 reported accumulating preliminary evidence that the Mediterranean dietary pattern may be associated with IBS symptom relief, with olive oil serving as the primary fat source within that pattern. That said, large-scale clinical trials isolating olive oil's independent contribution have yet to be conducted.

Practical Considerations for Everyday Use

There are several practical points worth noting for anyone following a low-FODMAP plan who wants to incorporate olive oil.

First, olive oil functions well as a flavor-delivery vehicle in place of high-FODMAP aromatics like garlic and onion. Garlic's problematic compounds are water-soluble and do not leach into oil. Heating garlic cloves in olive oil and then removing them — a method referred to as garlic-infused oil — is an approach discussed in the low-FODMAP community and referenced in the Monash University app database as a way to carry garlic flavor without the oligosaccharides.

Second, cooking temperature and oil quality are linked. Extra virgin olive oil contains significantly higher levels of polyphenols than refined oils and is generally recommended for use in room-temperature dressings or lower-heat applications. Food science research has reported that extended high-heat cooking can cause some loss of phenolic compounds.

Third, individual response varies considerably. IBS presents across subtypes — IBS-C, IBS-D, IBS-M, and others — with triggers that differ from person to person. Clinical nutrition specialists commonly recommend keeping a detailed food diary to monitor individual reactions, since the same food can produce different outcomes depending on the person and context.

Limitations in the Research and the Road Ahead

The intersection of IBS and dietary fat is an active area of research, but important limitations remain. Most clinical trials conducted to date have involved small sample sizes and short follow-up periods, making it difficult to draw conclusions about long-term effects. The pathophysiology of IBS itself is entangled with complex, overlapping factors — the gut-brain axis, the intestinal microbiome, and visceral hypersensitivity among them — which makes isolating the effect of any single food genuinely difficult.

A 2023 review published in Alimentary Pharmacology & Therapeutics noted growing researcher interest in a hybrid approach that combines elements of the Mediterranean diet and the low-FODMAP diet, reporting that this combination may contribute to improved quality-of-life measures in IBS patients. In that framework, olive oil is described as a fat source that integrates naturally into both dietary patterns.

Researchers consistently emphasize that building an individual dietary plan in consultation with a registered dietitian or gastroenterologist is the most important step. Dietary modification is a complementary component of IBS management, and no single food — olive oil included — is considered a treatment.